GoodRx Holdings (GDRX) Receivables - Other (2025 - 2026)

GoodRx Holdings has disclosed Receivables - Other across 2 years of filings, most recently posting $11.9 million for Q2 2026.

• In Q2 2026, Receivables - Other changed N/A year-over-year to $11.9 million; the TTM figure through Jun 2026 stood at $11.9 million (changed N/A YoY), while the FY2025 annual figure was $11.9 million, changed N/A from the prior year.
• Receivables - Other came in at $11.9 million for Q2 2026 at GoodRx Holdings, roughly flat from $11.9 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $11.9 million in Q4 2025 to a low of $11.9 million in Q4 2025.